Zurich Cantonal Bank’s Ginkgo Bioworks DNA Stock Holding History

Zurich Cantonal Bank’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.7K	Hold	3,700	–	–	﹤0.01%	2454
2025 Q4	$30.7K	Hold	3,700	–	–	﹤0.01%	2454
2025 Q3	$53.9K	Hold	3,700	–	–	﹤0.01%	2449
2025 Q2	$41.6K	Hold	3,700	–	–	﹤0.01%	2473
2025 Q1	$21.1K	Hold	3,700	–	–	﹤0.01%	2557
2024 Q4	$36.3K	Hold	3,700	–	–	﹤0.01%	2575
2024 Q3	$30.2K	Sell	3,700 -1	-0%	-$10	﹤0.01%	2587
2024 Q2	$49.5K	Sell	3,701 -767	-17%	-$22.9K	﹤0.01%	2544
2024 Q1	$207K	Buy	4,468 +767	+21%	+$39.7K	﹤0.01%	2034
2023 Q4	$250K	Sell	3,701 -918	-20%	-$56.2K	﹤0.01%	1957
2023 Q3	$334K	Buy	4,619 +1,246	+37%	+$99.6K	﹤0.01%	1639
2023 Q2	$251K	Hold	3,373	–	–	﹤0.01%	1767
2023 Q1	$179K	Hold	3,373	–	–	﹤0.01%	1938
2022 Q4	$228K	Buy	3,373 +1,639	+95%	+$151K	﹤0.01%	1749
2022 Q3	$216K	Hold	1,734	–	–	﹤0.01%	1711
2022 Q2	$165K	Buy	+1,734	New	+$211K	﹤0.01%	1912

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zurich Cantonal Bank's DNA Position: Q1 2026 in Review

Zurich Cantonal Bank held its Ginkgo Bioworks (DNA) position steady in Q1 2026 at 3,700 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.

Zurich Cantonal Bank first reported a position in DNA in Q2 2022 and has held it in 16 quarters since. The position peaked at $334K in Q3 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Zurich Cantonal Bank held 3,700 shares of Ginkgo Bioworks worth $22.7K as of Q1 2026.
Zurich Cantonal Bank left its Ginkgo Bioworks share count unchanged in Q1 2026.
Ginkgo Bioworks made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2454 holding.
Zurich Cantonal Bank first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 16 quarters since.
Zurich Cantonal Bank's Ginkgo Bioworks position peaked at $334K in Q3 2023.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.